Franchi Jean M. 4

What Happened
Jean M. Franchi, Chief Financial Officer of Disc Medicine (IRON), was granted two equity awards on 2026-02-10 totaling 44,500 shares: 19,000 restricted stock units (RSUs) and a 25,500-share derivative award. Both awards were reported at a $0 acquisition price (no cash paid). These are grant/award transactions (code A), not open-market purchases or sales.

Key Details

• Transaction date: 2026-02-10; Form 4 filed 2026-02-11 (timely).
• Awards: 19,000 RSUs (F1) and 25,500-share derivative award (F2). Reported price: $0 for both.
• Vesting (from footnotes):
  • F1 (19,000 RSUs): each RSU converts to one share; vesting annually in four equal 25% installments beginning Feb 15, 2027, subject to continued service.
  • F2 (25,500 derivative): underlying shares vest in 48 equal monthly installments beginning March 10, 2026, subject to continued service.
• Shares owned after transaction: Not specified in this Form 4.
• No tax-withholding sale or immediate disposition reported in this filing.
• Transaction code: A = Award/Grant. Filing was timely (not late).

Context
RSUs and time‑vesting derivative awards are common forms of executive compensation and only convert into tradable shares as they vest; they are not immediate market purchases or sales. This filing documents granted compensation that vests over multiple years and does not by itself indicate a buy/sell trading decision.